Por favor, use este identificador para citar o enlazar este ítem:
https://repositorio.uca.edu.ar/handle/123456789/15361
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Otero Losada, Matilde | es |
dc.contributor.author | Petrovsky, Nikolai | es |
dc.contributor.author | Alami, Abdallah | es |
dc.contributor.author | Crispo, James A. G. | es |
dc.contributor.author | Mattison, Donald | es |
dc.contributor.author | Capani, Francisco | es |
dc.contributor.author | Goetz, Christopher | es |
dc.contributor.author | Krewski, Daniel | es |
dc.contributor.author | Pérez Lloret, Santiago | es |
dc.date.accessioned | 2022-10-31T12:33:45Z | - |
dc.date.available | 2022-10-31T12:33:45Z | - |
dc.date.issued | 2022 | - |
dc.identifier.citation | Otero Losada, M. et al. Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1(Oxford-AstraZeneca) and BNT162b2 (Pfizer- BioNTech) COVID-19 vaccines in the United Kingdom [en línea]. Expert Opinion on Drug Safety. 2022. doi: 10.1080/14740338.2022.2120607. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/15361 | es |
dc.identifier.issn | 1474-0338 (impreso) | - |
dc.identifier.issn | 1744-764X (en línea) | - |
dc.identifier.uri | https://repositorio.uca.edu.ar/handle/123456789/15361 | - |
dc.description.abstract | Abstract: Background: Information on neurological and psychiatric adverse events following immunization (AEFIs) with COVID-19 vaccines is limited. Research design & methods: We examined and compared neurological and psychiatric AEFIS reports related to BNT162b2 (Pfizer-BioNTech) and ChAdOx1 (Oxford-AstraZeneca) COVID-19 vaccines and recorded in the United Kingdom Medicines and Healthcare products Regulatory Agency between 9 December 2020 and 30 June 2021. Results: As of 30 June 2021, 46.1 million doses of ChAdOx1 and 30.3 million doses of BNT162b2 had been administered. The most frequently reported AEFI was headache with 1,686 and 575 cases per million doses of ChAdOx1 and BNT162b2, respectively. AEFIs more frequently reported after CHAdOx1 compared with BNT162b2 vaccination were Guillain-Barré syndrome (OR, 95% CI = 2.53, 1.82–3.51), freezing (6.66, 3.12–14.22), cluster headache (1.53, 1.28–1.84), migraine (1.23,1.17–1.30), postural dizziness (1.24,1.13–1.37), tremor (2.86, 2.68–3.05), headache (1.40, 1.38–1.43), paresthesia (1.11, 1.06–1.16), delirium (1.85, 1.45–2.36), hallucination (2.20, 1.82–2.66), poor quality sleep (1.53, 1.26–1.85), and nervousness (1.54, 1.26–1.89) Reactions less frequently reported with ChAdOx1 than with BNT162b2 were Bell’s palsy (0.47, 0.41–0.55), anosmia (0.58, 0.47–0.71), facial paralysis (0.35, 0.29– 0.41), dysgeusia (0.68, 0.62–0.73), presyncope (0.48, 0.42–0.55), syncope (0.63, 0.58–0.67), and anxiety (0.75 (0.67–0.85). Conclusion: Neurological and psychiatric AEFIs were relatively infrequent, but each vaccine was associated with a distinctive toxic profile. Plain Language Summary We examined reports on adverse neurological and psychiatric effects following immunization with BNT162b2 (Pfizer-BioNTech) and ChAdOx1 (Oxford-AstraZeneca) for COVID-19 to the United Kingdom Medicines and Healthcare products Regulatory Agency between 9 December 2020 and 30 June 2021. Adverse effects following immunization (AEFIs) were relatively infrequent. Compared to BNT162b2, Guillain-Barré syndrome, freezing phenomenon, cluster headache, migraine, postural dizziness, tremor, headache, paresthesia, delirium, hallucination, poor quality sleep, and nervousness were more frequently reported for ChAdOx1. Reactions less frequently reported for ChAdOx1 than for BNT162b2 were Bell’s palsy, anosmia, facial paralysis, dysgeusia, presyncope, syncope, and anxiety. | es |
dc.format | application/pdf | es |
dc.language.iso | eng | es |
dc.publisher | Taylor & Francis | es |
dc.rights | Acceso restringido | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
dc.source | Expert Opinion on Drug Safety. 2022 | es |
dc.subject | COVID-19 | es |
dc.subject | BNT162b2 | es |
dc.subject | VACUNAS | es |
dc.subject | ChAdOx1 | es |
dc.subject | FARMACOLOGIA | es |
dc.subject | NEUROLOGIA | es |
dc.subject | PSIQUIATRIA | es |
dc.subject | VIGILANCIA | es |
dc.subject | EFECTOS ADVERSOS | es |
dc.title | Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1(Oxford-AstraZeneca) and BNT162b2 (Pfizer- BioNTech) COVID-19 vaccines in the United Kingdom | es |
dc.type | Artículo | es |
dc.identifier.doi | 10.1080/14740338.2022.2120607 | - |
uca.disciplina | MEDICINA | es |
uca.issnrd | 1 | es |
uca.affiliation | Fil: Otero Losada, Matilde. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | es |
uca.affiliation | Fil: Otero Losada, Matilde. Universidad Abierta Interamericana. Centro de Altos Estudios en Ciencias Humanas y de La Salud; Argentina | es |
uca.affiliation | Fil: Petrovsky, Nikolai. Universidad de Flinders; Australia | es |
uca.affiliation | Fil: Petrovsky, Nikolai. Vaxine; Australia | es |
uca.affiliation | Fil: Alami, Abdallah. Universidad de Ottawa. Facultad de Medicina. Centro McLaughlin para la Evaluación de Riesgos para la Salud de la Población; Canadá | es |
uca.affiliation | Fil: Alami, Abdallah. Risk Sciences International; Canadá | es |
uca.affiliation | Fil: Crispo, James A. G. Universidad de Carleton. Escuela de Matemáticas y Estadística; Canadá | es |
uca.affiliation | Fil: Crispo, James A. G. Escuela de Medicina del Norte de Ontario. División de Ciencias Humanas; Canadá | es |
uca.affiliation | Fil: Crispo, James A. Universidad de British Columbia. Facultad de Ciencias Farmacéuticas; Canadá | es |
uca.affiliation | Fil: Mattison, Donald. Vaxine; Australia | es |
uca.affiliation | Fil: Mattison, Donald. Risk Sciences International; Canadá | es |
uca.affiliation | Fil: Mattison, Donald. Universidad de Carolina del Sur. Arnold School of Public Health; Estdos Unidos | es |
uca.affiliation | Fil: Mattison, Donald. Universidad de Ottawa. Escuela de Epidemiología y Salud Pública; Canadá | es |
uca.affiliation | Fil: Capani, Francisco. Universidad Abierta Interamericana. Centro de Altos Estudios en Ciencias Humanas y de La Salud; Argentina | es |
uca.affiliation | Fil: Capani, Francisco. Universidad Autónoma de Chile. Facultad de Ciencias de la Salud; Chile | es |
uca.affiliation | Fil: Capani, Francisco. Universidad John F. Kennedy. Departamento de Biología; Argentina | es |
uca.affiliation | Fil: Goetz, Christopher. Universidad Rush. Centro Médico. Departamento de Ciencias Neurológicas; Estados Unidos | es |
uca.affiliation | Fil: Krewski, Daniel. Universidad de Ottawa. Facultad de Medicina. Centro McLaughlin para la Evaluación de Riesgos para la Salud de la Población; Canadá | es |
uca.affiliation | Fil: Krewski, Daniel. Risk Sciences International; Canadá | es |
uca.affiliation | Fil: Pérez Lloret, Santiago. Pontificia Universidad Católica Argentina. Laboratorio de Investigación en Ciencia de Datos; Argentina | es |
uca.affiliation | Fil: Pérez Lloret, Santiago. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Fisiología; Argentina | es |
uca.version | publishedVersion | es |
item.languageiso639-1 | en | - |
item.grantfulltext | reserved | - |
item.fulltext | With Fulltext | - |
crisitem.author.dept | Facultad de Psicología y Psicopedagogía | - |
crisitem.author.dept | Centro de Investigaciones en Psicología y Psicopedagogía (CIPP) | - |
crisitem.author.dept | Consejo Nacional de Investigaciones Científicas y Técnicas | - |
crisitem.author.dept | Instituto de Investigaciones Cardiológicas | - |
crisitem.author.dept | Laboratorio de Neurobiología Molecular | - |
crisitem.author.dept | Consejo Nacional de Investigaciones Científicas y Técnicas | - |
crisitem.author.orcid | 0000-0003-0342-0628 | - |
crisitem.author.orcid | 0000-0001-9069-6512 | - |
crisitem.author.parentorg | Pontificia Universidad Católica Argentina | - |
crisitem.author.parentorg | Facultad de Psicología y Psicopedagogía | - |
crisitem.author.parentorg | Consejo Nacional de Investigaciones Científicas y Técnicas | - |
crisitem.author.parentorg | Instituto de Investigaciones Biomédicas - BIOMED | - |
Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | Usuarios registrados haga click en: Login |
---|---|---|---|---|
disproportionality-analysis-adverse.pdf | 651,6 kB | Adobe PDF |
Visualizaciones de página(s)
82
comprobado en 27-abr-2024
Descarga(s)
13
comprobado en 27-abr-2024
Google ScholarTM
Consultar
Altmetric
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons